Apogee Therapeutics Inc (NASDAQ: APGE) started the day on Wednesday, with a price decrease of -7.95% at $52.79, before settling in for the price of $57.35 at the close. Taking a more long-term approach, APGE posted a 52-week range of $14.91-$72.29.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 0.00%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 10.37%. This publicly-traded company’s shares outstanding now amounts to $37.17 million, simultaneously with a float of $36.11 million. The organization now has a market capitalization sitting at $3.09 billion. At the time of writing, stock’s 50-day Moving Average stood at $54.73, while the 200-day Moving Average is $49.58.
Apogee Therapeutics Inc (APGE) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Apogee Therapeutics Inc’s current insider ownership accounts for 38.26%, in contrast to 80.09% institutional ownership. According to the most recent insider trade that took place on Nov 06 ’24, this organization’s Chief Medical Officer sold 6,665 shares at the rate of 59.12, making the entire transaction reach 394,041 in total value, affecting insider ownership by 267,463. Preceding that transaction, on Nov 06 ’24, Company’s Chief Executive Officer sold 15,000 for 59.22, making the whole transaction’s value amount to 888,320. This particular insider is now the holder of 1,339,487 in total.
Apogee Therapeutics Inc (APGE) Earnings and Revenue Records
Apogee Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 10.37% and is forecasted to reach -4.31 in the upcoming year.
Apogee Therapeutics Inc (NASDAQ: APGE) Trading Performance Indicators
Let’s observe the current performance indicators for Apogee Therapeutics Inc (APGE). It’s Quick Ratio in the last reported quarter now stands at 16.39. The Stock has managed to achieve an average true range (ATR) of 3.44.
In the same vein, APGE’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.73, a figure that is expected to reach -1.06 in the next quarter, and analysts are predicting that it will be -4.31 at the market close of one year from today.
Technical Analysis of Apogee Therapeutics Inc (APGE)
If we take a close look at the recent performances of Apogee Therapeutics Inc (NASDAQ: APGE), its last 5-days Average volume was 0.46 million that shows plunge from its year to date volume of 0.49 million. During the previous 9 days, stock’s Stochastic %D was recorded 46.66% While, its Average True Range was 3.79.
Raw Stochastic average of Apogee Therapeutics Inc (APGE) in the period of the previous 100 days is set at 60.44%, which indicates a major rise in contrast to 17.74% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 64.03% that was higher than 56.09% volatility it exhibited in the past 100-days period.
